Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.

Peiffer-Smadja, Nathan; Rebeaud, Mathieu E; Guihur, Anthony; Mahamat-Saleh, Yahya; Fiolet, Thibault

Peiffer-Smadja, Nathan; Rebeaud, Mathieu E; Guihur, Anthony; Mahamat-Saleh, Yahya; Fiolet, Thibault.

Peiffer-Smadja N; Université de Paris, INSERM, IAME, F-75006 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Infectious and Tropical Diseases Department, Bichat-Claude Bernard H
Rebeaud ME; Department of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.
Guihur A; Department of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.
Mahamat-Saleh Y; Centre for Research in Epidemiology and Population Health, INSERM "Health across Generations" Team, Paris-Sud 11 University/Paris Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.
Fiolet T; Centre for Research in Epidemiology and Population Health, INSERM "Health across Generations" Team, Paris-Sud 11 University/Paris Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.

Lancet Infect Dis ; 21(5): e121, 2021 05.

Article in English | MEDLINE | ID: covidwho-1510468

Subject(s)

COVID-19 Drug Treatment; Hydroxychloroquine; Chloroquine; Humans; Hydroxychloroquine/adverse effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google